Trials / Unknown
UnknownNCT02698813
Safety Study of Filler Agent Composed of Umbilical Cord Mesenchymal Stem Cells and Hyaluronic Acid
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- South China Research Center for Stem Cell and Regenerative Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The overall goal of this study is to evaluate the safety and exploratory efficacy of the injectable filler agent composed of umbilical cord mesenchymal stem cells and hyaluronic acid for the improvement of wrinkles, acne, pitting scar and so on.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | umbilical cord mesenchymal stem cells and hyaluronic acid | |
| DRUG | hyaluronic acid |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2018-12-01
- First posted
- 2016-03-04
- Last updated
- 2016-03-04
Source: ClinicalTrials.gov record NCT02698813. Inclusion in this directory is not an endorsement.